Fanouriakis A - Search Results

1

Neuropsychiatric lupus or not? Cerebral hypoperfusion by perfusion-weighted MRI in normal-appearing white matter in primary neuropsychiatric lupus erythematosus.

Papadaki E, Fanouriakis A, Kavroulakis E, Karageorgou D, Sidiropoulos P, Bertsias G, Simos P, Boumpas DT. Papadaki E, et al. Among authors: fanouriakis a. Ann Rheum Dis. 2018 Mar;77(3):441-448. doi: 10.1136/annrheumdis-2017-212285. Epub 2017 Dec 19. Ann Rheum Dis. 2018. PMID: 29259047

2

Balancing efficacy and toxicity of novel therapies in systemic lupus erythematosus.

Fanouriakis A, Boumpas DT, Bertsias GK. Fanouriakis A, et al. Expert Rev Clin Pharmacol. 2011 Jul;4(4):437-51. doi: 10.1586/ecp.11.23. Expert Rev Clin Pharmacol. 2011. PMID: 22114854 Review.

3

Recent progress in the treatment of lupus nephritis.

Fanouriakis A, Krasoudaki E, Tzanakakis M, Boumpas DT. Fanouriakis A, et al. Mod Rheumatol. 2012 Nov;22(6):803-13. doi: 10.1007/s10165-012-0655-4. Epub 2012 May 15. Mod Rheumatol. 2012. PMID: 22584472 Review.

4

Hepatitis B reactivation following treatment with abatacept in a patient with past hepatitis B virus infection.

Fanouriakis A, Vassilopoulos D, Repa A, Boumpas DT, Sidiropoulos P. Fanouriakis A, et al. Rheumatology (Oxford). 2014 Jan;53(1):195-6. doi: 10.1093/rheumatology/ket221. Epub 2013 Jun 14. Rheumatology (Oxford). 2014. PMID: 23771951 No abstract available.

5

Pathogenesis and treatment of CNS lupus.

Fanouriakis A, Boumpas DT, Bertsias GK. Fanouriakis A, et al. Curr Opin Rheumatol. 2013 Sep;25(5):577-83. doi: 10.1097/BOR.0b013e328363eaf1. Curr Opin Rheumatol. 2013. PMID: 23836074 Review.

6

Control of flares and relief of urate burden with canakinumab and targeted urate-lowering therapy in tophaceous gouty arthritis.

Fanouriakis A, Karantanas A, Fragouli E, Repa A, Sidiropoulos P. Fanouriakis A, et al. Rheumatology (Oxford). 2014 Apr;53(4):764-6. doi: 10.1093/rheumatology/ket327. Epub 2013 Oct 31. Rheumatology (Oxford). 2014. PMID: 24185764 No abstract available.

7

Coexistence of systemic lupus erythematosus and multiple sclerosis: prevalence, clinical characteristics, and natural history.

Fanouriakis A, Mastorodemos V, Pamfil C, Papadaki E, Sidiropoulos P, Plaitakis A, Amoiridis G, Bertsias G, Boumpas DT. Fanouriakis A, et al. Semin Arthritis Rheum. 2014 Jun;43(6):751-8. doi: 10.1016/j.semarthrit.2013.11.007. Epub 2013 Nov 13. Semin Arthritis Rheum. 2014. PMID: 24332007

8

EULAR recommendations for neuropsychiatric systemic lupus erythematosus vs usual care: results from two European centres.

Pamfil C, Fanouriakis A, Damian L, Rinzis M, Sidiropoulos P, Tsivgoulis G, Rednic S, Bertsias G, Boumpas DT. Pamfil C, et al. Among authors: fanouriakis a. Rheumatology (Oxford). 2015 Jul;54(7):1270-8. doi: 10.1093/rheumatology/keu482. Epub 2015 Jan 30. Rheumatology (Oxford). 2015. PMID: 25638807

9

Rituximab for eosinophilic granulomatosis with polyangiitis with severe vasculitic neuropathy: Case report and review of current clinical evidence.

Fanouriakis A, Kougkas N, Vassilopoulos D, Fragouli E, Repa A, Sidiropoulos P. Fanouriakis A, et al. Semin Arthritis Rheum. 2015 Aug;45(1):60-6. doi: 10.1016/j.semarthrit.2015.03.004. Epub 2015 Mar 26. Semin Arthritis Rheum. 2015. PMID: 25908179 Review.

10

Cyclophosphamide in combination with glucocorticoids for severe neuropsychiatric systemic lupus erythematosus: a retrospective, observational two-centre study.

Fanouriakis A, Pamfil C, Sidiropoulos P, Damian L, Flestea A, Gusetu G, Rednic S, Bertsias G, Boumpas DT. Fanouriakis A, et al. Lupus. 2016 May;25(6):627-36. doi: 10.1177/0961203315622821. Epub 2015 Dec 21. Lupus. 2016. PMID: 26692040

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

116 results

Search Page

Filters